Jubilant Life Sciences surges on plan to raise Rs 2,000 crore through redeemable NCDs

10 Sep 2014 Evaluate

Jubilant Life Sciences is currently trading at Rs 180.00, up by 4.10 points or 2.33% from its previous closing of Rs 175.90 on the BSE...

The scrip opened at Rs 177.50 and has touched a high and low of Rs 181.15 and Rs 177.50 respectively. So far 27907 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 1 has touched a 52 week high of Rs. 222.00 on 13-Jun-2014 and a 52 week low of Rs. 72.00 on 21-Oct-2013.

Last one week high and low of the scrip stood at Rs. 177.80 and Rs. 162.00 respectively. The current market cap of the company is Rs. 2801.76 crore.

The promoters holding in the company stood at 54.02% while Institutions and Non-Institutions held 27.58% and 18.39% respectively.

Drug firm Jubilant Life Sciences has received its shareholders’ approval to raise Rs 2,000 crore through redeemable non-convertible debentures (NCDs) on a private placement basis or rights basis in one or more tranches. Additionally, the borrowing through debentures will be within the above overall borrowing limit of Rs 5,000 crore.

Jubilant Life Sciences is engaged in manufacture and supply of active pharmaceutical ingredient (APIs), solid dosage formulations, radio pharmaceuticals, allergy therapy products and life science ingredients. It also provides services in contract manufacturing of sterile injectables and ointments, creams and liquids and drug discovery and development.

 

Jubilant Pharmova Share Price

1062.65 -11.65 (-1.08%)
29-Dec-2025 11:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1726.30
Dr. Reddys Lab 1262.75
Cipla 1500.80
Zydus Lifesciences 904.55
Lupin 2094.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×